Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension
The effectiveness and safety of valsartan have not been assessed in hypertensive children. Therefore, hypertensive patients aged 6 to 16 years (n=261) were randomized to receive weight‐stratified low‐ (10/20 mg), medium‐ (40/80 mg), or high‐dose (80/160 mg) valsartan for 2 weeks. After 2 weeks, pati...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , , , , , |
---|---|
Формат: | Artigo |
Хэл сонгох: | англи |
Хэвлэсэн: |
2011
|
Онлайн хандалт: | https://doi.org/10.1111/j.1751-7176.2011.00432.x |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|